<img height="1" width="1" src="https://www.facebook.com/tr?id=414339248965737&amp;ev=PageView &amp;noscript=1">

Eyes on Research

DPHARM 2024 Key Takeaways: Streamlining Site Feasibility and Patient Access

20/20 Onsite

Why Ophthalmology Assessments Are Non-Negotiable

20/20 Onsite

Convenient and Comprehensive Care: Best Practices for Pediatric Clinical Trials

By 20/20 Onsite

In her Clinical Leader guest column, pediatrician Katie Smentek, MD, FAAP, emphasized the importance of prioritizing safety and comfort in pediatric clinical trial environments. Addressing the unique... Read More

Vision for the Future: Key Takeaways from ARVO and OIS 2024

By 20/20 Onsite

What happens when nearly 800 people step aboard a full-service eye clinic on wheels? Industry-changing conversations and innovative ideas converge, all centered around integrating point-of-need care... Read More

Improving Clinical Trial Access: Positive Impacts on Patient Retention

By 20/20 Onsite

Read More

Our Eye-Opening Takeaways from the ARVO 2023 Annual Meeting

By 20/20 Onsite

In late April, several members from our Life Sciences team attended and exhibited at the Association for Research in Vision and Ophthalmology(ARVO) 2023 Annual Meeting in New Orleans, LA. Read More

World Optometry Day: Creating Patient-First Vision Care, Together

By 20/20 Onsite

Read More

SCRS Global Site Solutions Summit 2022: 20/20 Onsite’s Recap

By 20/20 Onsite

This October, several members of our Life Sciences team had the opportunity to attend the 2022 SCRS Global Site Solutions Summit as an Alliance Sponsor. The Summit is committed to being known as “the... Read More

Why Optometrists Love Delivering Accessible Clinical Vision Care at 20/20 Onsite

By 20/20 Onsite

As pioneers in mobile vision care, we continue to pursue our mission of providing high-quality, accessible eye care directly to patients, while introducing innovative concepts along the way. Read More

Trends in Clinical Site Staffing and How Mobile Care Can Help

By 20/20 Onsite

Technological advancements, changing cultural expectations around data diversity, and “The Great Resignation” have all hit the life sciences industry at the same time as a global pandemic. Read More